XML 25 R11.htm IDEA: XBRL DOCUMENT v3.19.1
Financial Instruments
3 Months Ended
Mar. 31, 2019
Financial Instruments  
Financial Instruments

5. Financial Instruments

The Company elected to invest a portion of its cash assets in conservative, income earning, and liquid investments. Cash equivalents and investments, all of which are classified as available-for-sale securities, consisted of the following:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

March 31, 2019

 

December 31, 2018

 

 

    

Amortized
Cost

    

Gross
Unrealized
Gain

    

Gross
Unrealized
Loss

    

Estimated Fair Value

    

Amortized
Cost

    

Gross
Unrealized
Gain

    

Gross
Unrealized
Loss

    

Estimated Fair Value

 

 

 

(in thousands)

 

Money market deposits

 

$

588

 

$

 —

 

$

 —

 

$

588

 

$

26,539

 

$

 —

 

$

 —

 

$

26,539

 

U.S. Treasury securities

 

 

57,857

 

 

62

 

 

(287)

 

 

57,632

 

 

76,061

 

 

29

 

 

(405)

 

 

75,685

 

U.S. agency securities

 

 

13,010

 

 

 —

 

 

(72)

 

 

12,938

 

 

13,017

 

 

 —

 

 

(126)

 

 

12,891

 

Municipal securities

 

 

23,204

 

 

55

 

 

(24)

 

 

23,235

 

 

18,935

 

 

 7

 

 

(57)

 

 

18,885

 

Total

 

$

94,659

 

$

117

 

$

(383)

 

$

94,393

 

$

134,552

 

$

36

 

$

(588)

 

$

134,000

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Classified as:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Cash equivalents

 

 

 

 

 

 

 

 

 

 

$

588

 

 

 

 

 

 

 

 

 

 

$

26,539

 

Short-term investments

 

 

 

 

 

 

 

 

 

 

 

93,805

 

 

 

 

 

 

 

 

 

 

 

107,461

 

Total

 

 

 

 

 

 

 

 

 

 

$

94,393

 

 

 

 

 

 

 

 

 

 

$

134,000

 

 

The Company invests in U.S. Treasuries, U.S. agency and high quality municipal bonds which mature at par value and are all paying their coupons on schedule. The Company has therefore concluded there is currently no other than temporary impairment of its investments and will continue to recognize unrealized gains and losses in other comprehensive income (loss). During the three months ended March 31, 2019, there were no sales of investments, and during the three months ended March 31, 2018,  the amount of gross realized gains and realized losses upon sales of investments were insignificant. The Company uses the specific investment identification method to calculate realized gains and losses and amounts reclassified out of other comprehensive income to net income. As of March 31, 2019, the Company had 12 investments in an unrealized loss position in its portfolio.

The following table summarizes the Company’s portfolio of available-for-sale securities by contractual maturity as of March 31, 2019:

 

 

 

 

 

 

 

 

 

 

March 31, 2019

 

 

 

Amortized
Cost

 

Fair
Value

 

 

 

(in thousands)

 

Less than one year

 

$

57,974

 

$

57,910

 

Greater than one year but less than five years

 

 

36,097

 

 

35,895

 

Total

 

$

94,071

 

$

93,805